CG Oncology CGON Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's operating lease right-of-use assets in other assets?
- CG Oncology (CGON) reported operating lease right-of-use assets in other assets of $4.51M in Q1 2026.
- How has CG Oncology's operating lease right-of-use assets in other assets changed year-over-year?
- CG Oncology's operating lease right-of-use assets in other assets increased by 336.8% year-over-year, from $1.03M to $4.51M.
- What is the long-term trend for CG Oncology's operating lease right-of-use assets in other assets?
- Over 2 years (2023 to 2025), CG Oncology's operating lease right-of-use assets in other assets has grown at a 206.8% compound annual growth rate (CAGR), from $422K to $3.97M.